Gabriela A Pizzurro

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Dendritic Cells

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Kate Bridges, Gabriela A Pizzurro, Mihir Khunte, Meibin Chen, Erick Salvador Rocha, Amanda F Alexander, Victor Bass, Laura N Kellman, Janani P Baskaran, Kathryn Miller-Jensen
Single-Cell Analysis Reveals a Subset of High IL-12p40-Secreting Dendritic Cells within Mouse Bone Marrow-Derived Macrophages Differentiated with M-CSF. Journal of immunology (Baltimore, Md. : 1950) 212 (8) (2024)
Kate Bridges, Gabriela A Pizzurro, Mihir Khunte, Meibin Chen, Erick Salvador Rocha, Amanda F Alexander, Victor Bass, Laura N Kellman, Janani P Baskaran, Kathryn Miller-Jensen
Single-Cell Analysis Reveals a Subset of High IL-12p40-Secreting Dendritic Cells within Mouse Bone Marrow-Derived Macrophages Differentiated with M-CSF. Journal of immunology (Baltimore, Md. : 1950) 212 (8) (2024)
Kate Bridges, Gabriela A Pizzurro, Mihir Khunte, Meibin Chen, Erick Salvador Rocha, Amanda F Alexander, Victor Bass, Laura N Kellman, Janani P Baskaran, Kathryn Miller-Jensen
Single-Cell Analysis Reveals a Subset of High IL-12p40-Secreting Dendritic Cells within Mouse Bone Marrow-Derived Macrophages Differentiated with M-CSF. Journal of immunology (Baltimore, Md. : 1950) (2024)
Gabriela A Pizzurro, Kate Bridges, Xiaodong Jiang, Aurobind Vidyarthi, Kathryn Miller-Jensen, Oscar R Colegio
Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors. Cancers 15 (13) (2023)
Irina Krykbaeva, Kate Bridges, William E Damsky, Gabriela A Pizzurro, Amanda F Alexander, Meaghan K McGeary, Koonam Park, Viswanathan Muthusamy, Jim Eyles, Nadia Luheshi, Noel Turner, Sarah A Weiss, Kelly Olino, Susan M Kaech, Harriet M Kluger, Kathryn Miller-Jensen, Marcus W Bosenberg
Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance. Cancer immunology research (2023)